VERA (VERA) Stock Price & Analysis
VERA (VERA) rose 2.57% to USD 35.89 as of September 8, 2026 at 05:48 UTC, according to Nexqual real-time market data.
VERA last closed at USD 35.89; the session ranged USD 34.69–36.41 on volume of 1,184,658 shares. Market capitalization is —, with a 52-week range of USD 22.72–56.05 (NGM). Source: Nexqual, September 8, 2026 at 05:48 UTC.
Key Statistics (as of September 8, 2026 at 05:48 UTC)
| Price | USD 35.89 |
|---|---|
| Change | ▲ 2.57% (up) |
| Previous Close | USD 35.89 |
| Open | USD 35.89 |
| Day Range | USD 34.69 – 36.41 |
| 52-Week Range | USD 22.72 – 56.05 |
| Volume | 1,184,658 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (VERA)
Nexqual's technical model rates VERA "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 05:48 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 55.33 (neutral) |
| vs SMA50 | Above (USD 35.89) |
| MACD | 0.32 (positive) |
From VERA's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| JANX | Janux Therapeutics, Inc. | USD 20.24 | ▲ 2.74% |
| EWTX | Edgewise Therapeutics, Inc. | USD 43.07 | ▲ 2.6% |
| KYMR | Kymera Therapeutics, Inc. | USD 117.39 | ▼ 1.05% |
| TVTX | Travere Therapeutics, Inc. | USD 65.28 | ▼ 2.9% |
| VRDN | Viridian Therapeutics, Inc. | USD 22.92 | ▲ 0.61% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:48 UTC. This page is informational and not investment advice.